{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:02:07Z","timestamp":1761894127218},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T00:00:00Z","timestamp":1116806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T00:00:00Z","timestamp":1116806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1038\/sj.bmt.1705014","type":"journal-article","created":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T09:11:48Z","timestamp":1116839508000},"page":"91-97","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation"],"prefix":"10.1038","volume":"36","author":[{"given":"M","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Feuchtinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Greil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Barbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Niethammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,5,23]]},"reference":[{"key":"BF1705014_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJM199303043280901","volume":"328","author":"NA Kernan","year":"1993","unstructured":"Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593\u2013602.","journal-title":"N Engl J Med"},{"key":"BF1705014_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.bmt.1703667","volume":"30","author":"M Ortin","year":"2002","unstructured":"Ortin M, Raj R, Kinning E et al. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplant 2002; 30: 359\u2013366.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705014_CR3","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","volume":"101","author":"P Lang","year":"2003","unstructured":"Lang P, Handgretinger R, Niethammer D et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 2003; 101: 1630\u20131636.","journal-title":"Blood"},{"key":"BF1705014_CR4","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1182\/blood.V99.9.3151","volume":"99","author":"N Bunin","year":"2002","unstructured":"Bunin N, Carston M, Wall D et al. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002; 99: 3151\u20133157.","journal-title":"Blood"},{"key":"BF1705014_CR5","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","volume":"97","author":"V Rocha","year":"2001","unstructured":"Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962\u20132971.","journal-title":"Blood"},{"key":"BF1705014_CR6","first-page":"1927","volume":"92","author":"B Coiffier","year":"1998","unstructured":"Coiffier B, Haioun C, Ketterer N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998; 92: 1927\u20131932.","journal-title":"Blood"},{"key":"BF1705014_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1040-8428(00)00069-X","volume":"37","author":"S Sacchi","year":"2001","unstructured":"Sacchi S, Federico M, Dastoli G et al. Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab. Crit Rev Oncol Hematol 2001; 37: 13\u201325.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF1705014_CR8","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1182\/blood.V98.5.1326","volume":"98","author":"D Huhn","year":"2001","unstructured":"Huhn D, von Schilling C, Wilhelm M et al. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood 2001; 98: 1326\u20131331.","journal-title":"Blood"},{"key":"BF1705014_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1182\/blood.V99.3.754","volume":"99","author":"G Cartron","year":"2002","unstructured":"Cartron G, Dacheux L, Salles G et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002; 99: 754\u2013758.","journal-title":"Blood"},{"key":"BF1705014_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/74704","volume":"6","author":"RA Clynes","year":"2000","unstructured":"Clynes RA, Towers TL, Presta LG, Ravetch JV . Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 2000; 6: 443\u2013446.","journal-title":"Nat Med"},{"key":"BF1705014_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1046\/j.1365-2141.2002.03935.x","volume":"119","author":"J Golay","year":"2002","unstructured":"Golay J, Gramigna R, Facchinetti V et al. Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab. Br J Haematol 2002; 119: 923\u2013929.","journal-title":"Br J Haematol"},{"key":"BF1705014_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","volume":"101","author":"O Manches","year":"2003","unstructured":"Manches O, Lui G, Chaperot L et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood 2003; 101: 949\u2013954.","journal-title":"Blood"},{"key":"BF1705014_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2141.2003.04446.x","volume":"122","author":"A Shimoni","year":"2003","unstructured":"Shimoni A, Hardan I, Avigdor A et al. Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma. Br J Haematol 2003; 122: 457\u2013464.","journal-title":"Br J Haematol"},{"key":"BF1705014_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.bmt.1703406","volume":"29","author":"P Lang","year":"2002","unstructured":"Lang P, Pfeiffer M, Handgretinger R et al. Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children. Bone Marrow Transplant 2002; 29: 497\u2013502.","journal-title":"Bone Marrow Transplant"},{"issue":"1 Suppl. 2","key":"BF1705014_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.seminoncol.2003.12.008","volume":"31","author":"W Brugger","year":"2004","unstructured":"Brugger W . Clearing minimal residual disease with rituximab consolidation therapy. Semin Oncol 2004; 31 (1 Suppl. 2): 33\u201337.","journal-title":"Semin Oncol"},{"key":"BF1705014_CR16","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097\u20132100.","journal-title":"Science"},{"key":"BF1705014_CR17","first-page":"1002","volume":"88","author":"J Golay","year":"2003","unstructured":"Golay J, Manganini M, Facchinetti V et al. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Haematologica 2003; 88: 1002\u20131012.","journal-title":"Haematologica"},{"key":"BF1705014_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1046\/j.1365-2141.2002.03535.x","volume":"117","author":"JW Friedberg","year":"2002","unstructured":"Friedberg JW, Neuberg D, Gribben JG et al. Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma. Br J Haematol 2002; 117: 828\u2013834.","journal-title":"Br J Haematol"},{"key":"BF1705014_CR19","first-page":"238","volume":"31","author":"P Lang","year":"2003","unstructured":"Lang P, Greil J, Schumm M . Boosts with highly purified stem cells following allogeneic transplantation from alternative donors. Bone Marrow Transplant 2003; 31: 238.","journal-title":"Bone Marrow Transplant"},{"issue":"1 Suppl. 2","key":"BF1705014_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.seminoncol.2003.12.006","volume":"31","author":"P Hillmen","year":"2004","unstructured":"Hillmen P . Advancing therapy for chronic lymphocytic leukemia \u2013 the role of rituximab. Semin Oncol 2004; 31 (1 Suppl. 2): 22\u201326.","journal-title":"Semin Oncol"},{"key":"BF1705014_CR21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","volume":"63","author":"KC Anderson","year":"1984","unstructured":"Anderson KC, Bates MP, Slaughenhoupt BL et al. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 1984; 63: 1424\u20131433.","journal-title":"Blood"},{"key":"BF1705014_CR22","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1182\/blood-2003-05-1735","volume":"103","author":"P Lang","year":"2004","unstructured":"Lang P, Barbin K, Feuchtinger T et al. Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. Blood 2004; 103: 3982\u20133985.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705014","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:38:35Z","timestamp":1648082315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["BF1705014"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705014","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,23]]},"assertion":[{"value":"29 November 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}